BioIndustrial Manufacturing and Design Ecosystem – Trademark Portfolio
Entity Type: 99
BioIndustrial Manufacturing and Design Ecosystem holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include BIOMADE and BIOINDUSTRIAL MANUFACTURING AND DESIGN ECOSYSTEM. The owner is based in Saint Paul, MN.
1500 Gortner Ave., Room 110
Saint Paul, MN 55108
Showing of trademarks Trademarks
Trademark Classifications
BioIndustrial Manufacturing and Design Ecosystem's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does BioIndustrial Manufacturing and Design Ecosystem have?
BioIndustrial Manufacturing and Design Ecosystem has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does BioIndustrial Manufacturing and Design Ecosystem file in?
BioIndustrial Manufacturing and Design Ecosystem files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are BioIndustrial Manufacturing and Design Ecosystem's most well-known trademarks?
BioIndustrial Manufacturing and Design Ecosystem's registered trademark portfolio includes well-known marks such as BIOMADE and BIOINDUSTRIAL MANUFACTURING AND DESIGN ECOSYSTEM. These are among 3 currently registered trademarks in the portfolio.
What is BioIndustrial Manufacturing and Design Ecosystem's trademark registration success rate?
BioIndustrial Manufacturing and Design Ecosystem has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.